MedPath

Role of Dhataki Pushpa Churna in Heavy Menstrual Bleeding

Phase 4
Conditions
Health Condition 1: - Health Condition 2: N921- Excessive and frequent menstruation with irregular cycle
Registration Number
CTRI/2023/05/052474
Lead Sponsor
Ch. Brahm Prakash Ayurved Charak Sansthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Duration of menstrual flow >7days

Irregular and excessive Menstrual bleeding

Reduction in the inter menstrual cycle period

Patient with heavy menstrual bleeding since two consecutive cycles atleast

Exclusion Criteria

Patients with any co-morbities.

Coagulative Disorders

Patient with any other organic lesion i.e. uterine fibroid, ovarian cyst, carcinoma etc.

IUCD Pregnancy

Hb% < 8mg/dl

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Findings of the study will be beneficial in the clinical management of Asrugdara (Heavy <br/ ><br>menstrual bleeding) by establishing the efficacy of dhataki pushpa churna .Timepoint: Two Consecutive Cycles
Secondary Outcome Measures
NameTimeMethod
This study will provide cost effective, safe drug with lesser side effects <br/ ><br>Timepoint: Two Consecutive Cycles
© Copyright 2025. All Rights Reserved by MedPath